Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data (Q30744678)

26 June 2017

1 reference

title

Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data (English)

1 reference

26 June 2017

arterial hypertension

1 reference

based on heuristic

inferred from title

essential hypertension

1 reference

Franco Rabbia

3

0 references

author name string

Francesco Amenta

1

1 reference

26 June 2017

Fiorenzo Mignini

2

1 reference

26 June 2017

Daniele Tomassoni

4

1 reference

26 June 2017

Franco Veglio

5

1 reference

26 June 2017

1 November 2002

1 reference

Journal of the Neurological Sciences

26 June 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 June 2017

203-204

1 reference

26 June 2017

147-151

1 reference

[Cerebral complications of hypertension in the elderly]

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Antihypertensive drugs and incidence of dementia: the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

The treatment of hypertension in older people and its effect on cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Treatment of hypertension to prevent stroke: translating evidence into clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Cognitive performance in hypertensive and normotensive older subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Blood pressure and cognitive performance. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Treatment of hypertension in the elderly. III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs cooperative study. Department of Veterans Affairs Cooperative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

The effects of antihypertensive treatment on cognitive function: results from the HOPE study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

15-year longitudinal study of blood pressure and dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Impairment of memory function by antihypertensive medication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Transdermal clonidine compared with hydrochlorothiazide as monotherapy in elderly hypertensive males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Treating hypertension in the older person: an evaluation of the association of blood pressure level and its reduction with cognitive performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Effect of long-term treatment with antihypertensive drugs on quality of life of elderly patients with hypertension: a double-blind comparative study between a calcium antagonist and a diuretic. NICS-EH Study Group. National Intervention Cooperative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Treatment of arterial hypertension with diuretics, beta- and calcium channel blockers in old patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Memory performance by mild hypertensives following beta-adrenergic blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Effects of beta-blockade and exercise on cardiovascular and cognitive functioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Impact of beta-blockade on complex cognitive functioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Cognitive function in hypertensives treated with atenolol or propranolol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Effects of antihypertensive medications on quality of life in elderly hypertensive women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Use of computerized neuropsychological tests (CANTAB) to assess cognitive effects of antihypertensive drugs in the elderly. Cambridge Neuropsychological Test Automated Battery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

A comparison of verapamil and nifedipine on quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

[Effectiveness of felodipine in hypertensive patients with mild cerebral cognition disorders in a randomized double-blind study]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900281-2

10.1016/S0022-510X(02)00281-2

7 January 2021

Identifiers

DOI

1 reference

26 June 2017

1 reference